CYTK — CYTOKINETICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 510 SEC-registered investment managers reported holding CYTK (CYTOKINETICS INC) in their latest 13F filings, with a combined reported value of $11.71B across 212.27M shares. That is +19.9% by share count (+32.65M shares) versus the previous quarter, while reported value moved +55.9%. Ownership is concentrated: the five largest holders account for 41.2% of reported value and the top ten for 51.8%.
Compared with the prior quarter, 91 opened new positions, 246 added to existing stakes, 107 trimmed, 53 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of CYTOKINETICS INC (CYTK) include Shaolin Capital Management LLC, Taconic Capital Advisors LP, T. Rowe Price Investment Management, Inc., ranked by reported 13F value among the 844 institutional holders on this page.
CYTK is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 353 | 108.60M | $4.86B | +3.2% |
| Q2 2026 | 510 | 212.27M | $11.71B | +19.9% |
| Q1 2026 | 470 | 174.81M | $7.61B | -28.9% |
| Q4 2025 | 451 | 228.68M | $6.91B | -0.2% |
| Q3 2025 | 398 | 217.34M | $6.20B | +10.2% |
| Q2 2025 | 335 | 282.54M | $3.04B | +3.2% |
| Q1 2025 | 370 | 282.49M | $5.16B | -3.6% |
| Q4 2024 | 361 | 262.70M | $3.94B | -5.3% |
Over the 8 quarters shown, institutional share counts decreased 59% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2026 (-28.9%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 21.04M | $1.39B | 0.03% | Add | |
| 6.80M | $448.16M | 0.02% | Add | |
| 6.27M | $413.02M | 0.01% | Add | |
| 3.77M | $248.39M | 0.01% | Add | |
| 3.02M | $198.82M | 0.02% | Add | |
| 2.45M | $161.24M | 0.02% | Add | |
| 1.58M | $103.88M | 0.34% | Reduce | |
| 1.37M | $90.57M | 0.10% | Add | |
| 1.23M | $80.77M | 0.04% | Reduce | |
| 1.17M | $77.19M | 0.02% | Add | |
| 1.02M | $67.08M | 0.57% | Add | |
| 980.39K | $64.62M | 32.92% | Hold | |
| 944.84K | $62.27M | 0.03% | Reduce | |
| 930.36K | $61.32M | 0.01% | Add | |
| 910.49K | $59.76M | 0.10% | New | |
| 818.83K | $53.97M | 0.02% | Add | |
| 750.00K | $49.43M | 2.30% | Add | |
| 708.95K | $46.73M | 1.11% | Reduce | |
| 706.18K | $46.54M | 0.07% | Add | |
| 661.16K | $43.58M | 0.45% | New | |
| 660.31K | $43.52M | 2.09% | Hold | |
| 617.39K | $40.84M | 0.18% | Add | |
| 564.71K | $37.22M | 0.52% | Hold | |
| 548.88K | $36.18M | 0.05% | Add | |
| 520.72K | $34.32M | 0.01% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 17.72M | $1.13B | 0.71% | Reduce | |
| 16.40M | $1.04B | 0.03% | Add | |
| 12.05M | $765.54M | 0.01% | Add | |
| 5.83M | $370.14M | 0.01% | Add | |
| 3.34M | $212.03M | 3.78% | Reduce | |
| 3.06M | $194.21M | 0.01% | Add | |
| 2.72M | $172.90M | 1.73% | Hold | |
| 1.93M | $122.64M | 0.01% | Reduce | |
| 1.65M | $104.74M | 0.41% | Hold | |
| 1.38M | $87.90M | 0.01% | Add | |
| 1.38M | $87.90M | 0.01% | Add | |
| 1.38M | $87.74M | 0.01% | Reduce | |
| 12.50M | $75.41M | 0.86% | Hold | |
| 1.18M | $74.90M | 0.01% | Hold | |
| 1.13M | $71.89M | 0.04% | Add | |
| 992.77K | $63.08M | 0.79% | Reduce | |
| 980.39K | $62.29M | 36.36% | New | |
| 976.89K | $62.07M | 0.03% | Reduce | |
| 934.64K | $59.39M | 1.59% | Add | |
| 822.88K | $52.29M | 0.02% | Add | |
| 807.07K | $51.28M | 0.01% | Reduce | |
| 800.00K | $50.83M | 3.10% | Add | |
| 757.56K | $48.02M | 0.05% | Reduce | |
| 747.98K | $47.53M | 4.22% | Reduce | |
| 731.15K | $46.46M | 0.07% | Reduce |
Q3 2025 — 25 funds
Q2 2025 — 25 funds
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 3.71M sh · $316.33M
- Sixth Street Partners Management Company, L.P. 1.57M sh · $133.39M
- Holocene Advisors, LP 1.14M sh · $97.51M
- Hood River Capital Management LLC 469.27K sh · $39.98M
- Polaris Capital Management, LLC 266.90K sh · $22.74M
- Jupiter Topco LLC 244.42K sh · $20.82M
- BAKER BROS. ADVISORS LP 211.27K sh · $18.00M
- Tri Locum Partners LP 194.00K sh · $16.53M
- PFM Health Sciences, LP 191.69K sh · $16.33M
- Ghisallo Capital Management LLC 170.00K sh · $14.48M
- KINGDON CAPITAL MANAGEMENT, L.L.C. 157.10K sh · $13.38M
- Polymer Capital Management (HK) LTD 138.25K sh · $11.78M
Fully Exited (vs previous quarter)
- STATE STREET CORP sold 5.75M sh · $378.67M
- Paradigm Biocapital Advisors LP sold 1.48M sh · $97.60M
- Logos Global Management LP sold 875.00K sh · $57.67M
- MPM BioImpact LLC sold 500.00K sh · $32.95M
- Vestal Point Capital, LP sold 300.00K sh · $19.77M
- Ikarian Capital, LLC sold 283.57K sh · $18.69M
- Janus Henderson Group sold 282.12K sh · $18.59M
- Catalio Capital Management, LP sold 215.50K sh · $14.20M
- Monashee Investment Management LLC sold 100.00K sh · $6.59M
- Troluce Capital Advisors LLC sold 100.00K sh · $6.59M
- Sofinnova Investments, Inc. sold 91.79K sh · $6.05M
- SILVERARC CAPITAL MANAGEMENT, LLC sold 71.20K sh · $4.69M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 21.04M | 20.09M | 16.55M | 16.40M | 15.53M | 5.38M | 5.58M | 4.88M | 4.28M | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.80M | 6.71M | 5.84M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.27M | 6.12M | 5.49M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 3.77M | 3.71M | 3.22M | 3.06M | 3.04M | 2.99M | 2.94M | 2.84M | 2.85M | 2.74M | 2.25M | 2.09M | 1.98M | 1.91M | 1.73M | 1.66M | 1.59M | 1.48M | 1.47M | 1.43M |
| Invesco Ltd | 3.02M | 1.24M | 484.98K | 204.88K | 157.25K | 136.31K | 501.88K | 1.00M | 1.00M | 1.10M | 1.32M | 1.24M | 1.18M | 1.50M | 1.48M | 1.45M | 1.41M | 547.60K | 398.65K | 759.67K |
| Capital Research Global Investors | 2.45M | 1.69M | 771.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.58M | 1.60M | 1.09M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Pictet Asset Management Holding SA | 1.37M | 1.16M | 750.95K | 757.56K | 1.15M | 1.55M | 1.96M | 1.91M | 2.09M | 1.77M | 1.75M | 1.37M | 2.25M | — | — | — | — | — | — | — |
| Principal Global Investors | 1.23M | 1.31M | 1.09M | 976.89K | 1.17M | 1.18M | 629.91K | 271.13K | 273.08K | 393.58K | 431.56K | 521.17K | 525.28K | 555.72K | 582.90K | 665.38K | 612.45K | 673.27K | 658.15K | 677.12K |
| BNY Mellon | 1.17M | 200.00K | 200.00K | 200.00K | 300.00K | 200.00K | 200.00K | 200.00K | 200.00K | 200.00K | 200.00K | 400.00K | 400.00K | 1.29M | 1.28M | 1.32M | 1.37M | 1.14M | 840.69K | 881.17K |
| GW&K Investment Management, LLC | 1.02M | 916.11K | 494.62K | 472.36K | 180.67K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Royalty Pharma Sub-Manager, LLC | 980.39K | 980.39K | 980.39K | 980.39K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 944.84K | 1.17M | 24.90K | 1.13M | 19.80K | 3.07M | 581.00K | 1.20M | 600 | 299.60K | 298.74K | 12.80K | 91.30K | 318.10K | 266.93K | 335.22K | 210.90K | 164.48K | 248.02K | 244.37K |
| VANGUARD FIDUCIARY TRUST CO | 930.36K | 906.42K | 799.62K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| WCM INVESTMENT MANAGEMENT, LLC | 910.49K | — | — | — | — | — | — | — | 71.79K | 76.81K | 43.87K | — | — | — | — | — | — | — | — | — |
| Fisher Asset Management, LLC | 818.83K | 743.70K | 768.26K | 822.88K | 761.59K | 733.68K | 793.46K | 616.49K | 542.28K | 534.52K | 538.80K | 536.05K | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 750.00K | 550.00K | 700.48K | 800.00K | 350.00K | — | — | — | — | — | 80.00K | 160.00K | 230.37K | — | — | — | — | — | — | — |
| Siren, L.L.C. | 708.95K | 758.95K | 613.95K | — | — | — | — | 402.32K | 525.97K | — | — | — | — | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 706.18K | 689.08K | 854.37K | 579.86K | 247.47K | 290.25K | 237.60K | 24.65K | 40.29K | 55.92K | 171.55K | 198.89K | 102.81K | — | — | — | — | — | — | — |
| VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. | 661.16K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold CYTK?
As of 2026-Q2, 510 institutional funds reported holding CYTK (CYTOKINETICS INC) in SEC 13F filings, with a combined reported value of $11.71B.
How many shares of CYTK do institutions own?
13F filers reported 212.27M shares of CYTK, worth $11.71B in aggregate at the end of 2026-Q2.
Is institutional ownership of CYTK rising or falling?
Share counts moved +19.9% versus the prior quarter — accumulation.
Who are the top institutional holders of CYTK?
The largest 13F holders are Shaolin Capital Management LLC, Taconic Capital Advisors LP, T. Rowe Price Investment Management, Inc., BlackRock Inc, Vanguard Group; the top 25 are ranked at the top of this page.
Who are the major shareholders of CYTOKINETICS INC?
The major shareholders of CYTOKINETICS INC (CYTK) by reported 13F value are Shaolin Capital Management LLC, Taconic Capital Advisors LP, T. Rowe Price Investment Management, Inc., BlackRock Inc, Vanguard Group, among 844 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.